GGrantIndex
Sort

46,585 grants matching heart failure

Pharmacogenomic Evaluation of Antihypertensive Responses

$1,975,100
Julie A. Johnson · University Of Florida · U01 · FY2014 · GM

The ISCHEMIA Trial - SDCC

$1,975,010
Sean M O'Brien · Duke University · U01 · FY2019 · HL

Transition from Risk Factors to Early HF: Prevalence, Pathogenesis, and Phenomics

$1,974,550
Alain Gerald Bertoni · Wake Forest University Health Sciences · R01 · FY2015 · HL

INTERDISCIPLINARY STUDY OF DELIRIUM AND ITS LONG-TERM OUTCOMES

$1,972,037
Sharon K Inouye · Hebrew Rehabilitation Center For Aged · P01 · FY2014 · AG

Atrial fibrillation burden, vascular disease of the brain and cardiac MRI in MESA

$1,972,025
Susan Heckbert · University Of Washington · R01 · FY2017 · HL

Myocardial Hypertrophy and Heart Failure

$1,971,977
Univ Of Med/Dent Of Nj-Nj Medical School · P01 · FY2005 · HL

Combined Cardiopulmonary Failure in COPD: SPIROMICS HF

$1,971,654
R Graham Barr · Columbia University Health Sciences · R01 · FY2023 · HL

Molecular Basis of Dilated & Hypertrophic Cardiomyopathy

$1,971,638
David M Warshaw · University Of Vermont & St Agric College · P01 · FY2006 · HL

REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-4 (REGARDS-MI-4)

$1,971,468
Monika M Safford · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · HL

Magscrew TAH Testing thru Pre-Clinical Readiness

$1,970,369
Cleveland Clinic Foundation · R01 · FY2001 · HL

Stimulant and Polysubstance use, Inflammation and Sex Effects on Myocardial Disease in HIV (SPISE)

$1,969,877
Phyllis C Tien · Northern California Institute/Res/Edu · RM1 · FY2025 · DA

2/2: A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women

$1,969,560
Rebecca Gersnoviez Clifton · George Washington University · U24 · FY2021 · HL

JACKSON HEART STUDY (JHS) - COORDINATING CENTER (CC) - TO EXERCISE OPTION PERIOD THREE (3) AND REVISE CONTRACT ARTICLES.

$1,968,007
Mario Sims · University Of Mississippi Med Ctr · N01 · FY2021 · HL

Autonomic Cardiovascular Regulation

$1,966,934
David Herlie Robertson · Vanderbilt University · P01 · FY2006 · HL

Expression, Structure/function, Regulation, and Roles of PDE3 Isoforms

$1,962,327
Vincent Manganiello · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Vascular remodeling in patients with rare genetic disorders

$1,961,950
Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

Autonomic Cardiovascular Regulation

$1,961,341
Vanderbilt University · P01 · FY2005 · HL

ARIC CLINICAL EXAMINATION CENTER

$1,956,764
Gerardo Heiss · Univ Of North Carolina Chapel Hill · N01 · FY2014 · HL

Framingham Heart Study/Fox

$1,956,697
Caroline Fox · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-4 (REGARDS-MI-4)

$1,953,999
Monika M Safford · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · HL

Unravelling immunoregulatory circuits of T cells

$1,952,772
Behdad Afzali · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK

The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial EXTENDed Follow-up (EXTEND)

$1,952,501
Judith S Hochman · New York University School Of Medicine · R01 · FY2024 · HL

Mechanisms of cardiovascular remodeling

$1,951,668
Anthony Martin Gerdes · University Of South Dakota · P20 · FY2008 · RR

Native-Controlling Hypertension And Risk through Technology (Native-CHART)

$1,950,419
Dedra S Buchwald · Washington State University · U54 · FY2017 · MD

Heart failure proteomics: an epidemiology study

$1,950,139
Veronique Roger · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL